Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Myosana Therapeutics
2617 Nw 59th St., Apt 102
Seattle, WA 98107
Phone: 206-465-3004
https://www.myosanatherapeutics.com/

Myosana Therapeutics, Inc. is leading the efforts in developing new gene therapies that will slow skeletal muscle degeneration and heart failure to improve the quality of life, increase longevity and reduce the disease burden of Duchenne muscular dystrophy (DMD) and other neuromuscular diseases.

Key Contact
Name
Steve Runnels
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
04/22/20 $1,000,000 Seed CureDuchenne Ventures
undisclosed
01/25/23 $5,000,000 Seed John Ballantyne
Muscular Dystrophy Association
Parent Project Muscular Dystrophy
undisclosed